Arthritis is an umbrella term that literally means inflammation of the joints. Over 100 different types exist, of which the most common is osteoarthritis (OA).

One in two people over the age of 60 show X-ray evidence of this process in which cartilage protecting the bone ends weakens and flakes away. This triggers an inflammatory response in which the underlying bone swells and the joint space narrows. Eventually, the bone ends may rub together, causing increasing pain, stiffness and deformity. Any joints can be affected, but it is most common in the larger, weight-bearing joints such as the hips, knees and spine.

Treatment options are limited

Until recently, osteoarthritis pain was mainly treated by oral painkillers such as paracetamol or non-steroidal anti-inflammatory drugs such as ibuprofen. Their prolonged use is now limited by concerns that they may increase the risk of heart attack or stroke. The long-term use of non-steroidal anti-inflammatory drugs is also limited by their intestinal side effects and peptic ulceration risks.

As oral painkillers have fallen out of fashion, topical painkilling creams and gels are gaining in popularity, as are natural approaches such as taking food supplements and using magnetic therapy to reduce pain and aid healing.

“I have used magnetic therapy for over twenty years, and found personal benefit from wearing a Trion:Z bracelet that generates both a magnetic field and negative ions. Although many people like to rubbish the use of these innovative approaches for well-being, I urge you to try it for yourself and form a genuine opinion without jumping to a knee-jerk conclusion.” – Dr Sarah Brewer , MSC (NUTR MED), MA (CANTAB), MB, BCHIR, RNUTR, MBANT, CNHC, FRSM

SIGN UP BELOW to get your FREE eBook from Dr. Sarah Brewer on the Benefits of Magnetic Therapy and the TRION:Z Clinical Trial 

You will receive an email containing the link to FREE downloadable PDF files. You are free to unsubscribe from our email list at any point, and we promise not to pass or sell your contact details to third-parties.